Ashley Moody
42
Moderate self-dealing
3/6 components have data
#9 of 193 scored
Ashley Moody, appointed to the U.S. Senate in January 2025, drew scrutiny for up to ~$3.3M in individual-stock trades during her first months in office, including health-sector holdings such as Eli Lilly while serving on the Health (HELP) Committee, which CNN flagged for committee-sector overlap. Her office attributes the trades to an extended-family investment partnership that acted without her direction, says she exited and stopped trading after April 2025, and notes she co-sponsors a bipartisan bill to ban congressional stock trading. She has accepted roughly $531,500 in corporate PAC money and raised ~$5.8M in 2025, a correlation-not-causation pattern of donor concentration aligned with her committees. Her vote attendance is strong (1.1% missed), and no public evidence was found of campaign personal-use violations, revolving-door conflicts, or net-worth enrichment beyond market over her short tenure.
Public record
- In Congress since
- 2025
- Committees
- Armed Services
Health, Education, Labor, and Pensions
Homeland Security and Governmental Affairs
Judiciary
Joint Economic Committee
Senate Special Committee on Aging - Missed votes, 119th Congress
- 1.2% (11 of 907; median member 1.9%)
- Campaign money, 2025–26 cycle
- $11M raised · 18% from PACs & committees · $8.5M cash on hand FEC ↗
The stock-trading ban
Senate cloture on H.R. 7008, Sep 30, 2026
YesCosponsored a ban bill
S. 3649H.R. 7008 bans new stock purchases by members, spouses and dependents; it doesn't force sales of existing holdings. The Senate vote was on the version paired with the SAVE Act, which is why no Democrat voted yes. Full breakdown →
Disclosed stock trades
57trades since Jan 2025
16buys
41sells
0filed past 45 days
$1.1M–$3.3Mdisclosed value range
Most-traded: MU ×1 · AMAT ×1 · HWM ×1 · OKTA ×1
| Traded | Filed | Owner | Asset | Type | Amount | |
|---|---|---|---|---|---|---|
| Apr 4, 2025 | May 13, 2025 | Member | ET | Buy | $15,001 - $50,000 | filing ↗ |
| Apr 4, 2025 | May 13, 2025 | Member | JPM | Buy | $15,001 - $50,000 | filing ↗ |
| Apr 4, 2025 | May 13, 2025 | Member | ARCC | Buy | $15,001 - $50,000 | filing ↗ |
| Apr 4, 2025 | May 13, 2025 | Member | HWM | Buy | $15,001 - $50,000 | filing ↗ |
| Mar 25, 2025 | Apr 20, 2025 | Member | SMCI PUT | Sell | $1,001 - $15,000 | filing ↗ |
| Mar 25, 2025 | Apr 20, 2025 | Member | SMCI CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Mar 25, 2025 | Apr 20, 2025 | Member | SMCI CALL | Partial sell | $1,001 - $15,000 | filing ↗ |
| Mar 25, 2025 | Apr 20, 2025 | Member | SMCI CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Mar 25, 2025 | Apr 20, 2025 | Member | NVDA CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Mar 25, 2025 | Apr 20, 2025 | Member | SMCI | Buy | $100,001 - $250,000 | filing ↗ |
| Mar 24, 2025 | Apr 20, 2025 | Member | SMCI | Partial sell | $15,001 - $50,000 | filing ↗ |
| Mar 21, 2025 | Apr 20, 2025 | Member | NVDA | Buy | $15,001 - $50,000 | filing ↗ |
| Mar 20, 2025 | Apr 20, 2025 | Member | NVDA | Buy | $100,001 - $250,000 | filing ↗ |
| Mar 6, 2025 | Mar 22, 2025 | Member | LLY | Buy | $100,001 - $250,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | CRWD PUT | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | CCL PUT | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | OKTA PUT | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | AMD | Buy | $100,001 - $250,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | SMCI | Partial sell | $50,001 - $100,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | SMCI | Partial sell | $15,001 - $50,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | HWM | Sell | $50,001 - $100,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | AMAT CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | ASML CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | CRSP CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | ARDX CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | NCLH CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | NCLH CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | QQQ M CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | SYM CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | SYM CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | TFC CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | WYNN CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | GENI | Buy | $1,001 - $15,000 | filing ↗ |
| Feb 24, 2025 | Mar 22, 2025 | Member | ASML | Buy | $50,001 - $100,000 | filing ↗ |
| Feb 20, 2025 | Mar 22, 2025 | Member | KPTI | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 20, 2025 | Mar 22, 2025 | Member | DM | Sell | $1,001 - $15,000 | filing ↗ |
| Feb 20, 2025 | Mar 22, 2025 | Member | ADCT | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 27, 2025 | Feb 21, 2025 | Member | NVDA PUT | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 27, 2025 | Feb 21, 2025 | Member | AMAT PUT | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 27, 2025 | Feb 21, 2025 | Member | AMAT | Buy | $100,001 - $250,000 | filing ↗ |
| Jan 27, 2025 | Feb 21, 2025 | Member | NCLH CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 27, 2025 | Feb 21, 2025 | Member | AMAT CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 23, 2025 | Feb 21, 2025 | Member | DELL CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | SMCI PUT | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | NVDA PUT | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | AMAT CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | AMD CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | CCL CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | MU CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | SMCI CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | SMCI CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | HWM CALL | Sell | $1,001 - $15,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | MU Micron Technology | Buy | $50,001 - $100,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | AMAT Applied Materials | Buy | $100,001 - $250,000 | filing ↗ |
| Jan 22, 2025 | Feb 21, 2025 | Member | HWM Howmet Aerospace Inc | Buy | $50,001 - $100,000 | filing ↗ |
| Jan 21, 2025 | Feb 21, 2025 | Member | AMAT | Buy | $100,001 - $250,000 | filing ↗ |
| Jan 21, 2025 | Feb 21, 2025 | Member | OKTA Okta Inc Cl A | Sell | $50,001 - $100,000 | filing ↗ |
Amounts are the ranges members must report, not exact values. The STOCK Act requires a report within 45 days of a trade; "late" counts days past that deadline, measured to the filing date.
How the score breaks down
Stock self-tradinghousehold / spouse
25% weight
62
Reported up to ~$3.3M in individual-stock transactions across Jan-Apr 2025 (her first months in office), including up-to-$250K buys in Applied Materials, AMD, Nvidia, Super Micro, Micron, and a ~$175K Eli Lilly purchase (3/6/2025). CNN flagged sector overlap: she sits on the HELP (health) Committee and held/traded health-care names like Eli Lilly. Office says trades were made by an extended-family investment partnership without her direction; she says she exited and has not traded since April 2025. No public market-beating-return analysis available. Elevated for volume and committee-sector overlap; tempered by the family-partnership attribution and her co-sponsorship of a trading ban.
Disclosed up to ~$3.3M in trades in early 2025 (Applied Materials, AMD, Eli Lilly, Nvidia, Super Micro, Micron); office says a family investment partner directed them and she stopped trading after April 2025.Data aggregatornasdaq.com ↗CNN analysis: Moody bought ~$175K of Eli Lilly on 3/6/2025 while serving on the Health (HELP) Committee, which released a drug-pricing report citing Eli Lilly testimony.News reportingcnn.com ↗
Net-worth enrichment in officeno data
15% weight
—
Moody was sworn in January 2025; her federal tenure (~17 months) is too short and lacks comparable filed disclosures to measure net-worth growth beyond salary and market returns. Pre-office wealth (~$4.4M as Florida AG, 2023) is not scored. No evidence of enrichment beyond market identified.
Money → action alignmentcorrelation, not proof of any quid-pro-quo
20% weight
35
Correlation, not proof. As a freshman she has accepted ~$531,500 in corporate PAC money since the start of 2025, with advocacy-group reporting noting donations from defense, health-insurance, private-prison, and oil/gas interests alongside committee work and votes aligned with those sectors. This reflects donor concentration and vote alignment typical of her committees (Armed Services, HELP, Judiciary); no quid-pro-quo is alleged or established.
Advocacy report: Moody accepted ~$531,500 in corporate PAC money since the start of 2025, citing alignment with private prisons, health insurers, defense contractors, and oil and gas.News reportingendcitizensunited.org ↗FEC candidate overview documenting Moody's campaign committee receipts and contributors.Official recordfec.gov ↗
Campaign-fund personal useno data
15% weight
—
No public reporting or FEC findings identified indicating personal use of campaign or leadership-PAC funds. Absence of evidence is not treated as a violation.
Revolving door & familyno data
15% weight
—
No evidence found of family members lobbying tied to her office, family contracts linked to her position, or a notable staff-to-lobbyist pipeline during her short Senate tenure.
Skips the job to fundraise
10% weight
8
Strong attendance: missed only 9 of 822 roll-call votes (1.1%) from Jan 2025-June 2026, better than the Senate median (~2.8%). She raised ~$5.8M in 2025 for her 2026 race, but heavy fundraising is not paired with vote-skipping; no evidence of paid speeches displacing duties. Low score reflects diligent attendance.
Sources behind this score: 1 data aggregator · 4 news reporting · 2 official record · 2 reference database. Score = weighted average of the components that have data; the 3 without sourced evidence are excluded, never counted against the member. Methodology →
Embed this score on your site
Updates automatically when the score changes.
Right of reply
Is something here wrong or missing context? Members and their staff can send a correction or a statement. Statements are published on this page in full, and corrections go in the public log. Email corrections@greederboard.com.